These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33451274)

  • 21. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.
    Kortekaas J; Ketelaar J; Vloet RP; Loeffen WL
    Vet Microbiol; 2011 Jan; 147(1-2):11-8. PubMed ID: 20541334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
    von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
    Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination influences the evolution of classical swine fever virus.
    Ji W; Niu DD; Si HL; Ding NZ; He CQ
    Infect Genet Evol; 2014 Jul; 25():69-77. PubMed ID: 24747964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
    Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
    Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs.
    Muñoz-González S; Perez-Simó M; Muñoz M; Bohorquez JA; Rosell R; Summerfield A; Domingo M; Ruggli N; Ganges L
    Vet Res; 2015 Jul; 46(1):78. PubMed ID: 26159607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
    Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
    Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classical swine fever vaccines-State-of-the-art.
    Blome S; Moß C; Reimann I; König P; Beer M
    Vet Microbiol; 2017 Jul; 206():10-20. PubMed ID: 28069290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel chimeric E2CD154 subunit vaccine is safe and confers long lasting protection against classical swine fever virus.
    Suárez-Pedroso M; Sordo-Puga Y; Sosa-Teste I; Rodriguez-Molto MP; Naranjo-Valdés P; Sardina-González T; Santana-Rodríguez E; Montero-Espinosa C; Frías-Laporeaux MT; Fuentes-Rodríguez Y; Pérez-Pérez D; Oliva-Cárdenas A; Pereda CL; González-Fernández N; Bover-Fuentes E; Vargas-Hernández M; Duarte CA; Estrada-García MP
    Vet Immunol Immunopathol; 2021 Apr; 234():110222. PubMed ID: 33690056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
    de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
    Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classical swine fever in China: a minireview.
    Luo Y; Li S; Sun Y; Qiu HJ
    Vet Microbiol; 2014 Aug; 172(1-2):1-6. PubMed ID: 24793098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy evaluation of different CSF vaccines in pigs with CSF maternally derived antibodies.
    Chen N; Wang Q; Hu Y; Sun Y; Li J; Wu H; Xu L; Liu H; Yang C; Chen X; Deng Y; Xia Y; Zhang Q; Cheng S; Fan A; Chen G
    Vet Microbiol; 2022 Oct; 273():109541. PubMed ID: 36027683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
    Aebischer A; Müller M; Hofmann MA
    Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
    Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
    Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marker vaccine strategies and candidate CSFV marker vaccines.
    Dong XN; Chen YH
    Vaccine; 2007 Jan; 25(2):205-30. PubMed ID: 16934915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs.
    Dewulf J; Laevens H; Koenen F; Mintiens K; de Kruif A
    Prev Vet Med; 2004 Oct; 65(3-4):121-33. PubMed ID: 15488266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of classical swine fever vaccine virus in blood and tissue samples of pigs vaccinated either with a conventional C-strain vaccine or a modified live marker vaccine.
    Koenig P; Hoffmann B; Depner KR; Reimann I; Teifke JP; Beer M
    Vet Microbiol; 2007 Mar; 120(3-4):343-51. PubMed ID: 17147979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
    Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S
    Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.
    Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F
    Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
    Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.
    Zhou B; Liu K; Jiang Y; Wei JC; Chen PY
    Virol J; 2011 Jul; 8():378. PubMed ID: 21801433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.